Why Moderna Stock Surged Today
Shares of Moderna (NASDAQ: MRNA) popped on Wednesday after the biotech leader announced positive clinical trial results for its experimental skin cancer vaccine, developed with healthcare giant .
By the close of trading, Moderna's stock price was up more than 15%.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
€48.62
2.320%
Our community is currently high on Moderna Inc. with 11 Buy predictions and 8 Sell predictions.
On the other hand, the target price of 21 € is below the current price of 48.62 € for Moderna Inc., so the potential is actually -56.8%.
